Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.

Shah AH, Sowrirajan B, Davis ZB, Ward JP, Campbell EM, Planelles V, Barker E.

Cell Host Microbe. 2010 Nov 18;8(5):397-409. doi: 10.1016/j.chom.2010.10.008.


The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.

Matusali G, Potestà M, Santoni A, Cerboni C, Doria M.

J Virol. 2012 Apr;86(8):4496-504. doi: 10.1128/JVI.05788-11. Epub 2012 Feb 1.


HIV-1 Vpu affects the anterograde transport and the glycosylation pattern of NTB-A.

Bolduan S, Hubel P, Reif T, Lodermeyer V, Höhne K, Fritz JV, Sauter D, Kirchhoff F, Fackler OT, Schindler M, Schubert U.

Virology. 2013 Jun 5;440(2):190-203. doi: 10.1016/j.virol.2013.02.021. Epub 2013 Mar 22.


HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts.

Ward J, Bonaparte M, Sacks J, Guterman J, Fogli M, Mavilio D, Barker E.

Blood. 2007 Aug 15;110(4):1207-14. Epub 2007 May 18.


The natural killer cell cytotoxic function is modulated by HIV-1 accessory proteins.

Sowrirajan B, Barker E.

Viruses. 2011 Jul;3(7):1091-111. doi: 10.3390/v3071091. Epub 2011 Jul 8. Review.


HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface.

Dubé M, Paquay C, Roy BB, Bego MG, Mercier J, Cohen EA.

Traffic. 2011 Dec;12(12):1714-29. doi: 10.1111/j.1600-0854.2011.01277.x. Epub 2011 Oct 3.


HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.

Richard J, Sindhu S, Pham TN, Belzile JP, Cohen EA.

Blood. 2010 Feb 18;115(7):1354-63. doi: 10.1182/blood-2009-08-237370. Epub 2009 Dec 14.


Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity.

Cerboni C, Neri F, Casartelli N, Zingoni A, Cosman D, Rossi P, Santoni A, Doria M.

J Gen Virol. 2007 Jan;88(Pt 1):242-50.


HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.

Alvarez RA, Hamlin RE, Monroe A, Moldt B, Hotta MT, Rodriguez Caprio G, Fierer DS, Simon V, Chen BK.

J Virol. 2014 Jun;88(11):6031-46. doi: 10.1128/JVI.00449-14. Epub 2014 Mar 12.


β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.

Tervo HM, Homann S, Ambiel I, Fritz JV, Fackler OT, Keppler OT.

Retrovirology. 2011 Feb 10;8:9. doi: 10.1186/1742-4690-8-9.


HIV-1 Vpu interference with innate cell-mediated immune mechanisms.

Sandberg JK, Andersson SK, Bächle SM, Nixon DF, Moll M.

Curr HIV Res. 2012 Jun;10(4):327-33. Review.


HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain.

Bolduan S, Reif T, Schindler M, Schubert U.

Virology. 2014 Sep;464-465:375-84. doi: 10.1016/j.virol.2014.07.034. Epub 2014 Aug 9.


The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.

Rong L, Zhang J, Lu J, Pan Q, Lorgeoux RP, Aloysius C, Guo F, Liu SL, Wainberg MA, Liang C.

J Virol. 2009 Aug;83(15):7536-46. doi: 10.1128/JVI.00620-09. Epub 2009 May 27.


Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice.

Sato K, Misawa N, Fukuhara M, Iwami S, An DS, Ito M, Koyanagi Y.

J Virol. 2012 May;86(9):5000-13. doi: 10.1128/JVI.07062-11. Epub 2012 Feb 22.


HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.

Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, Brunetta E, Mavilio D, Planelles V, Barker E.

PLoS Pathog. 2009 Oct;5(10):e1000613. doi: 10.1371/journal.ppat.1000613. Epub 2009 Oct 2.


Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.

Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M.

FASEB J. 2013 Jun;27(6):2440-50. doi: 10.1096/fj.12-223057. Epub 2013 Feb 8.


Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Vigan R, Neil SJ.

J Virol. 2010 Dec;84(24):12958-70. doi: 10.1128/JVI.01699-10. Epub 2010 Oct 6.


Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation.

Kuhl BD, Sloan RD, Donahue DA, Liang C, Wainberg MA.

Virology. 2011 Sep 1;417(2):353-61. doi: 10.1016/j.virol.2011.06.012. Epub 2011 Jul 14.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk